Quantum Biopharma Ltd. Files June 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jun 3, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their June 6-K, confirming 20-F submission.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 3, 2025, reporting for the month of June 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing serves as an update for investors regarding Quantum Biopharma's regulatory reporting status and confirms their submission of a Form 20-F, which is typically used for annual reports by foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- June 3, 2025 (date) — Filing date
- 20250603 (date) — Conformed period of report
- Toronto, Ontario (location) — Company headquarters
- Form 20-F (document) — Report type
- Form 6-K (document) — Filing type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is filed by Quantum Biopharma Ltd. to report information that it has made or will make public pursuant to the laws of Canada or its constituent political subdivisions, or a stock exchange in Canada, or that it has submitted or will submit to security holders, as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the filing date and reporting period for this document?
The filing date is June 3, 2025, and the conformed period of report is also June 3, 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Does Quantum Biopharma Ltd. file its annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files or will file annual reports under cover of Form 20-F.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 3, 2025 regarding Quantum Biopharma Ltd. (QNTM).